WallStSmart
GLUE

Monte Rosa Therapeutics Inc

NASDAQ: GLUE · HEALTHCARE · BIOTECHNOLOGY

$8.64
-3.03% today

Updated 2026-11-20

Market cap
$880.99M
P/E ratio
—
P/S ratio
12.53x
EPS (TTM)
$-1.39
Dividend yield
—
52W range
$9 – $26
Volume
1.4M

Monte Rosa Therapeutics Inc (GLUE) Financial Forecast & Price Target 2030

Revenue-driven projection model with historical context.

Price target summary

Current price
$8.64
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—

Financial forecast

Metric20212022202320242025
Revenue$0.0B$0.0B$0.0B$0.1B$0.1B
EPS—————
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -186.20%

Methodology

CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.